Lexaria Bioscience (LEXX) Net Equity Issued and Repurchased (2011 - 2026)
Lexaria Bioscience's Net Equity Issued and Repurchased was $3.04 million in fiscal Q2 2026 (quarter ended Feb 28, 2026), compared with $11,720 a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Net Equity Issued and Repurchased at Lexaria Bioscience came in at $6.05 million, down 0.9% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- In earlier fiscal years, Net Equity Issued and Repurchased was $6.1 million in FY2024 (+283.9%), $1.59 million in FY2023 and $9.47 million in FY2021 (+255.0%).
- Quarterly Net Equity Issued and Repurchased has moved between -$121,687 (fiscal Q4 2023) and $4.35 million (fiscal Q1 2025) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 3.04 Mn |
| Nov 30, 2025 | 3.47 Mn |
| May 31, 2025 | 1.69 Mn |
| Feb 28, 2025 | 11,720.00 |
| Nov 30, 2024 | 4.35 Mn |
| Aug 31, 2024 | -2,875.00 |
| May 31, 2024 | 1.90 Mn |
| Feb 29, 2024 | 2.96 Mn |
| Nov 30, 2023 | 1.25 Mn |
| Aug 31, 2023 | -121,687.00 |
| May 31, 2023 | 1.71 Mn |
| Aug 31, 2021 | 4.02 Mn |
| Aug 31, 2020 | -46,571.00 |
| May 31, 2020 | 1.89 Mn |
| Feb 29, 2020 | 120,316.00 |
| Nov 30, 2019 | 706,704.00 |
| Aug 31, 2019 | -941,000.00 |
| May 31, 2019 | 1.24 Mn |
| Feb 28, 2019 | 381,299.00 |
| Nov 30, 2018 | 1.65 Mn |
API Access
Lexaria Bioscience Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();